Hanmi Pharmaceutical is revealing its messenger ribonucleic acid (mRNA) cancer vaccine and new targeted anticancer lead compounds. The company reinforced its anticancer pipeline by adding next-generation anticancer drug technologies and targets to its existing major anticancer drug pipeline that has been making smooth progress in preclinical trials.

According to industry sources on the 2nd, Hanmi Pharmaceutical will be presenting 7 abstracts related to its anticancer pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2023 held in Orlando, Florida from the 14th (local time) to the 19th.

At AACR 2023, the company will unveil abstracts about 2 lead compounds in